Beneficial ownership — 13D / 13G
87,387 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | NBRG Newbridge Acquisition Ltd | 13G | 8.7% | Mar 31, 2026 | 6mo |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | INO Inovio Pharmaceuticals, Inc. | 13G/A | 8.2% | Mar 31, 2026 | 6mo |
| Margaret E. Haas | LEVI Levi Strauss & Co | 13G/A | 30.2% | Mar 31, 2026 | 6mo |
| Auctus Fund Management LLC | BRTX BioRestorative Therapies, Inc. | 13G/A | 9.9% | Mar 31, 2026 | 6mo |
| PRICE T ROWE ASSOCIATES INC /MD/ | ELS Equity Lifestyle Properties Inc | 13G/A | 9.2% | Mar 31, 2026 | 6mo |
| Point72 Asset Management, L.P. | CCCC C4 Therapeutics, Inc. | 13G/A | 0.2% | Mar 31, 2026 | 6mo |
| PERCEPTIVE ADVISORS LLC | ALDX Aldeyra Therapeutics, Inc. | 13G/A | 0% | Mar 31, 2026 | 6mo |
| JANUS HENDERSON GROUP PLC | MAZE Maze Therapeutics, Inc. | 13G/A | 5.8% | Mar 31, 2026 | 6mo |
| Stonepine Capital Management, LLC | EDSA Edesa Biotech, Inc. | 13G/A | 0.3% | Mar 31, 2026 | 6mo |
| VIKING GLOBAL INVESTORS LP | INBX Inhibrx Biosciences, Inc. | 13G/A | 9.99% | Mar 31, 2026 | 6mo |
| WELLINGTON MANAGEMENT GROUP LLP | RWT Redwood Trust Inc | 13G/A | 8.8% | Mar 31, 2026 | 6mo |
| WELLINGTON MANAGEMENT GROUP LLP | CHEF Chefs' Warehouse, Inc. | 13G/A | 8.3% | Mar 31, 2026 | 6mo |
| Kenneth Griffin | UONE Urban One, Inc. | 13G/A | 0.3% | Mar 31, 2026 | 6mo |
| Merus Global Investments, LLC | DMYY dMY Squared Technology Group, Inc. | 13G/A | 0% | Mar 31, 2026 | 6mo |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | ARTC Art Technology Acquisition Corp. | 13G | 5.7% | Mar 31, 2026 | 6mo |
| ARMISTICE CAPITAL, LLC | CYCU Cycurion, Inc. | 13G/A | 4.99% | Mar 31, 2026 | 6mo |
| Sirenia Capital Management LP | KOD Kodiak Sciences Inc. | 13G | 5.7% | Mar 31, 2026 | 6mo |
| QVT Financial LP | CMTL Comtech Telecommunications Corp | 13G | 5.71% | Mar 31, 2026 | 6mo |
| Anson Funds Management LP | NXAT Nexus Advanced Technologies Inc. | 13G | 6.1% | Mar 31, 2026 | 6mo |
| WELLINGTON MANAGEMENT GROUP LLP | GENI Genius Sports Ltd | 13G/A | 0.6% | Mar 31, 2026 | 6mo |
| MMCAP International Inc. SPC | POET Poet Technologies Inc. | 13G/A | 9.99% | Mar 31, 2026 | 6mo |
| Silver Point Capital L.P. | MDRX Veradigm Inc. Common Stock | 13G/A | 3.27% | Mar 31, 2026 | 6mo |
| VIKING GLOBAL INVESTORS LP | TIC TIC Solutions, Inc. | 13G/A | 16.2% | Mar 31, 2026 | 6mo |
| Silver Point Capital L.P. | CLCO Cool Company Ltd. | 13G/A | 0% | Mar 31, 2026 | 6mo |
| COHEN & STEERS, INC. | UDR UDR, Inc. | 13G/A | 6.34% | Mar 31, 2026 | 6mo |
| TD SECURITIES (USA) LLC | GCTS GCT Semiconductor Holding, Inc. | 13G/A | 4.6% | Mar 31, 2026 | 6mo |
| DISCIPLINED GROWTH INVESTORS INC /MN | ALRM Alarm.com Holdings, Inc. | 13G/A | 6.6% | Mar 31, 2026 | 6mo |
| RTW INVESTMENTS, LP | BBNX Beta Bionics, Inc. | 13G/A | 4.5% | Mar 31, 2026 | 6mo |
| Alyeska Investment Group, L.P. | LINC Lincoln Educational Services Corp | 13G/A | 2.44% | Mar 31, 2026 | 6mo |
| WELLINGTON MANAGEMENT GROUP LLP | MCB Metropolitan Bank Holding Corp. | 13G/A | 9.8% | Mar 31, 2026 | 6mo |
| Deep Track Capital, LP | OCUL Ocular Therapeutix, Inc | 13G/A | 9.53% | Mar 31, 2026 | 6mo |
| Sirenia Capital Management LP | QTTB Q32 Bio Inc. | 13G | 9.9% | Mar 31, 2026 | 6mo |
| Anchorage Capital Group, L.L.C. | EQPT EquipmentShare.com Inc | 13G | 8.3% | Mar 31, 2026 | 6mo |
| Ikarian Capital, LLC | LPCN Lipocine Inc. | 13G | 6.3% | Mar 31, 2026 | 6mo |
| Anson Funds Management LP | ZNB Zeta Network Group | 13G | 8.2% | Mar 31, 2026 | 6mo |
| Sirenia Capital Management LP | IBIO iBio, Inc. | 13G | 9.9% | Mar 31, 2026 | 6mo |
| MSD CAPITAL, L.P. | TSQ Townsquare Media, Inc. | 13G/A | 7.2% | Mar 31, 2026 | 6mo |
| Empyrean Capital Partners, LP | BCSS Bain Capital GSS Investment Corp. | 13G/A | 9.26% | Mar 31, 2026 | 6mo |
| WELLINGTON MANAGEMENT GROUP LLP | HG Hamilton Insurance Group, Ltd. | 13G/A | 6.2% | Mar 31, 2026 | 6mo |
| RA CAPITAL MANAGEMENT, L.P. | AVTX Avalo Therapeutics, Inc. | 13G/A | 9.9% | Mar 31, 2026 | 6mo |
| L.I.A. Pure Capital Ltd. | QXL Quantum X Labs Inc. | 13G/A | 9.99% | Mar 31, 2026 | 6mo |
| MARATHON ASSET MANAGEMENT LP | EAF Graftech International Ltd | 13G/A | 4.7% | Mar 31, 2026 | 6mo |
| MORGAN STANLEY | BEBE TGE Value Creative Solutions Corp | 13G | 7.3% | Mar 31, 2026 | 6mo |
| PERCEPTIVE ADVISORS LLC | BDSX Biodesix Inc | 13G/A | 4.6% | Mar 31, 2026 | 6mo |
| RA CAPITAL MANAGEMENT, L.P. | UNCY Unicycive Therapeutics, Inc. | 13G/A | 9.9% | Mar 31, 2026 | 6mo |
| First Trust Capital Management L.P. | RAC Rithm Acquisition Corp. | 13G/A | 1.53% | Mar 31, 2026 | 6mo |
| PRICE T ROWE ASSOCIATES INC /MD/ | KEYS Keysight Technologies, Inc. | 13G/A | 8.7% | Mar 31, 2026 | 6mo |
| G1 Execution Services, LLC | LUNR Intuitive Machines, Inc. | 13G/A | 3.1% | Mar 31, 2026 | 6mo |
| PRICE T ROWE ASSOCIATES INC /MD/ | IP International Paper Co | 13G/A | 9.3% | Mar 31, 2026 | 6mo |
| NOVO HOLDINGS A/S | LNZA LanzaTech Global, Inc. | 13G/A | 1.6% | Mar 31, 2026 | 6mo |